YOLFTbeta
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A

Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A

688212 · SHG · Healthcare / Medical Devices

27.20CNY-0.54 (-1.95%)

Price History

Full chart

Market Stats

Previous Close27.74
Open28.37
Day Range27.13 – 28.44
52-Week Range24.89 – 53.01
Volume1.32M
Market Cap3.79B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.25
Dividend Yield0.00%
Beta-0.35
50-Day Avg28.56
200-Day Avg35.15

About

Shanghai Aohua Photoelectricity Endoscope Co., Ltd. engages in the research and development, manufacture, and sale of electronic endoscope equipment and endoscopic diagnosis and treatment consumables in China and internationally. It offers electronic digestive endoscopes, otolaryngoscopes, and endoscopic diagnostic and treatment consumables for use in respiratory medicine, general surgery, otolaryngology, orthopedics, urology, gynecology, gastroenterology, and emergency medicine. Shanghai Aohua Photoelectricity Endoscope Co., Ltd. was founded in 1994 and is based in Shanghai, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. Xiaozhou Gu
  • Employees1.12K
  • HeadquartersNo.66, Lane 133, Guangzhong Road, Shanghai, China, 201108, China
  • Websitehttps://www.aohua.com

Leadership

  • Mr. Xiaozhou GuGM & Chairman · b. 1984
  • Ms. Li Pan LiuDeputy General Manager · b. 1978
  • Mr. Chun YangKey Technical Personnel · b. 1981

Financials

Income Statement

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue297.75M263.28M347.05M445.26M678.08M749.55M773.87M
Growth (%)--11.58%+31.82%+28.30%+52.29%+10.54%+3.24%
Cost of Revenue93.53M85.96M106.59M134.80M205.20M238.93M269.00M
Gross Profit204.22M177.32M240.46M310.46M472.88M510.62M504.86M
Gross Margin68.59%67.35%69.29%69.73%69.74%68.12%65.24%
Operating Expense139.20M149.57M174.84M308.14M406.11M476.35M462.83M
Operating Income65.03M27.75M65.62M2.32M66.78M34.27M42.04M
Operating Margin21.84%10.54%18.91%0.52%9.85%4.57%5.43%
EBITDA66.76M45.16M84.23M52.85M103.28M71.98M80.23M
EBITDA Margin22.42%17.15%24.27%11.87%15.23%9.60%10.37%
Net Income52.91M18.51M57.04M21.66M57.85M21.01M11.45M
Net Income Margin17.77%7.03%16.43%4.87%8.53%2.80%1.48%
R&D30.45M39.23M49.35M96.54M147.00M163.60M147.01M
R&D as % of Total Revenue10.23%14.90%14.22%21.68%21.68%21.83%19.00%
Interest Expense1.24K-310.03K630.15K695.10K1.94M6.92M
Interest Expense % of Total Revenue0.00%-0.09%0.14%0.10%0.26%0.89%

Balance Sheet

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets599.55M631.59M1.35B1.46B1.60B1.75B2.00B
Total Liabilities78.39M86.79M90.36M178.46M199.88M368.20M670.42M
Total Equity511.80M534.29M1.25B1.27B1.38B1.37B1.31B
Cash162.25M176.79M766.82M230.17M244.55M267.20M341.86M

Cash Flow

Currency: CNY2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow47.39M71.52M66.15M-41.90M37.41M-78.93M-20.36M
Capital Expenditure65.50M61.83M91.61M78.77M157.83M186.63M130.39M
Free Cash Flow-18.11M9.69M-25.45M-120.67M-120.42M-265.55M-150.75M
Dividends Paid64.47K--25.33M1.63M41.60M16.58M
FCF to OCF-38.21%13.54%-38.48%287.99%-321.94%336.45%740.42%
Dividend Paid to FCF-0.36%---21.00%-1.35%-15.66%-11.00%

Earnings

Report DateApr 21, 2022Aug 24, 2022Oct 24, 2022Apr 24, 2023Aug 4, 2023
EPS Estimate-----
EPS Actual0.030.010.030.100.16
Surprise-----
TimingPre-marketAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap3.79B
Enterprise Value3.94B
Trailing P/E0.00
Forward P/E0.00
Price / Sales4.78
Price / Book3.18
EPS-0.25
Book Value9.08
Revenue (TTM)793.05M
Gross Profit (TTM)493.33M
EBITDA-5.29M
Profit Margin-4.21%
Operating Margin-50.41%
Return on Equity-2.64%
Return on Assets-1.93%
Shares Outstanding134.67M
Shares Float87.57M
Beta-0.35
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
0.08Jun 18, 2025
20241×
0.30Jun 17, 2024
20221×
0.19Jun 16, 2022